Cellyan Biotechnology Co., Ltd (HKPD) vs Sunshine Biopharma, Inc. (SBFM)
A side-by-side comparison of Cellyan Biotechnology Co., Ltd and Sunshine Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HKPD
Cellyan Biotechnology Co., Ltd
$0.10HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SBFM
Sunshine Biopharma, Inc.
$0.40HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — HKPD vs SBFM
growth of $100 · dividends reinvested · last 1yHKPD -83.8% (-83.8%/yr)SBFM -85.7% (-85.7%/yr)HKPD compounded faster over this window
HKPD SBFM
HKPD vs SBFM: by the numbers
- •HKPD is the larger company ($1M vs $946332 market cap).
- •Both run net losses; HKPD's is the smaller (-8.46% vs -16.50% net margin).
Metrics side by side
Valuation
| Metric | HKPD | SBFM |
|---|---|---|
| P/S ratio | N/A | 0.03 |
| P/B ratio | 0.12 | 0.03 |
Profitability
| Metric | HKPD | SBFM |
|---|---|---|
| Gross margin | 10.32% | 29.80% |
| Operating margin | -7.41% | -14.71% |
| Net margin | -8.46% | -16.50% |
| ROE | -11.85% | -21.18% |
| ROIC | -9.45% | -18.56% |
Growth (annualized)
| Metric | HKPD | SBFM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 203.18% |
Go deeper
Dig into the metrics
Cellyan Biotechnology ROESunshine Biopharma ROECellyan Biotechnology operating marginSunshine Biopharma operating marginCellyan Biotechnology revenue growthSunshine Biopharma revenue growthCellyan Biotechnology free cash flowSunshine Biopharma free cash flow
Cellyan Biotechnology & Sunshine Biopharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.